PL431336A1 - Lipopeptydy, kompozycja farmaceutyczna, kompozycja kosmetyczna oraz lipopeptydy do zastosowania jako lek - Google Patents

Lipopeptydy, kompozycja farmaceutyczna, kompozycja kosmetyczna oraz lipopeptydy do zastosowania jako lek

Info

Publication number
PL431336A1
PL431336A1 PL431336A PL43133619A PL431336A1 PL 431336 A1 PL431336 A1 PL 431336A1 PL 431336 A PL431336 A PL 431336A PL 43133619 A PL43133619 A PL 43133619A PL 431336 A1 PL431336 A1 PL 431336A1
Authority
PL
Poland
Prior art keywords
lipopeptides
medicine
pharmaceutical composition
composition
cosmetic composition
Prior art date
Application number
PL431336A
Other languages
English (en)
Other versions
PL241880B1 (pl
Inventor
Sławomir Sęk
Dagmara TYMECKA
Joanna Juhaniewicz-Dębińska
Dariusz BARTOSIK
Robert LASEK
Original Assignee
Uniwersytet Warszawski
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Warszawski filed Critical Uniwersytet Warszawski
Priority to PL431336A priority Critical patent/PL241880B1/pl
Priority to EP20800296.4A priority patent/EP4038084B1/en
Priority to PCT/IB2020/059149 priority patent/WO2021064593A1/en
Publication of PL431336A1 publication Critical patent/PL431336A1/pl
Publication of PL241880B1 publication Critical patent/PL241880B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Birds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Niniejszy wynalazek dotyczy nowych liniowych ultrakrótkich lipopeptydów, kompozycji farmaceutycznych i kosmetycznych zawierających lipopeptydy oraz lipopeptydów do zastosowania jako leki w leczeniu infekcji bakteryjnych.
PL431336A 2019-10-01 2019-10-01 Lipopeptydy, kompozycja farmaceutyczna, kompozycja kosmetyczna oraz lipopeptydy do zastosowania jako lek PL241880B1 (pl)

Priority Applications (3)

Application Number Priority Date Filing Date Title
PL431336A PL241880B1 (pl) 2019-10-01 2019-10-01 Lipopeptydy, kompozycja farmaceutyczna, kompozycja kosmetyczna oraz lipopeptydy do zastosowania jako lek
EP20800296.4A EP4038084B1 (en) 2019-10-01 2020-09-30 Lipopeptides, pharmaceutical composition, cosmetic composition, and lipopeptides for use as a drug
PCT/IB2020/059149 WO2021064593A1 (en) 2019-10-01 2020-09-30 Lipopeptides, pharmaceutical composition, cosmetic composition, and lipopeptides for use as a drug

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL431336A PL241880B1 (pl) 2019-10-01 2019-10-01 Lipopeptydy, kompozycja farmaceutyczna, kompozycja kosmetyczna oraz lipopeptydy do zastosowania jako lek

Publications (2)

Publication Number Publication Date
PL431336A1 true PL431336A1 (pl) 2021-04-06
PL241880B1 PL241880B1 (pl) 2022-12-19

Family

ID=75297930

Family Applications (1)

Application Number Title Priority Date Filing Date
PL431336A PL241880B1 (pl) 2019-10-01 2019-10-01 Lipopeptydy, kompozycja farmaceutyczna, kompozycja kosmetyczna oraz lipopeptydy do zastosowania jako lek

Country Status (3)

Country Link
EP (1) EP4038084B1 (pl)
PL (1) PL241880B1 (pl)
WO (1) WO2021064593A1 (pl)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL441789A1 (pl) * 2022-07-19 2024-01-22 Uniwersytet Warszawski Lipooligomoczniki, kompozycja farmaceutyczna, oraz lipooligomoczniki do zastosowania jako lek

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL441789A1 (pl) * 2022-07-19 2024-01-22 Uniwersytet Warszawski Lipooligomoczniki, kompozycja farmaceutyczna, oraz lipooligomoczniki do zastosowania jako lek

Also Published As

Publication number Publication date
WO2021064593A1 (en) 2021-04-08
PL241880B1 (pl) 2022-12-19
EP4038084B1 (en) 2023-11-01
EP4038084A1 (en) 2022-08-10

Similar Documents

Publication Publication Date Title
MX2021006421A (es) Anilidas de aminoácidos como moduladores de moléculas pequeñas de interleucinas-17 (il-17).
CL2021003477A1 (es) Compuestos 2,3-dihidroquinazolin como inhibidores nav1 .8
MX2022015272A (es) Inhibidores de la proteina kras g12c y usos de estos.
MY196909A (en) Boronic acid derivatives and therapeutic uses thereof
TR201901077T4 (tr) Kanser Veya Enfeksiyon Tedavisine Yönelik Birleşik Preparasyonlar
BR112018071831A2 (pt) composições anti-irritantes sinérgicas de taurina e aloé e métodos
EA201591541A1 (ru) Ингибиторы бета-секретазы 1 (bace 1)
MX340985B (es) Compuestos de n-heteroarilo.
ZA202201364B (en) Deuterated compounds for use in the treatment of cancer
BR112016016854A2 (pt) Derivados de 7-oxo-1,6-diazabiciclo[3.2.1]octana, seu processo de preparação e seu uso, composição farmacêutica e seu uso pedidos de patente relacionados
EP4272832A3 (en) Antimicrobial compounds, compositions, and uses thereof
PH12021551232A1 (en) Haloallylamine compounds and application thereof
CY1116234T1 (el) Υποκατεστημενα 2-οξυ-κινολινο-3-καρβοξαμιδια σαν διαμορφωτες kcnq2/3
EA202191515A1 (ru) Фармацевтическая композиция, содержащая апиксабан
ZA202300259B (en) Compound for the treatment of coronaviral infections
MX2023009921A (es) Formulaciones de proteinas de fusion ace2-fc.
CY1116158T1 (el) Υποκατεστημενα 2-οξο- και 2-θειοξο-διυδροκινολινο-3-καρβοξαμιδια σαν διαμορφωτες kcnq2/3
PL431336A1 (pl) Lipopeptydy, kompozycja farmaceutyczna, kompozycja kosmetyczna oraz lipopeptydy do zastosowania jako lek
MX2022000433A (es) Proteinas de fusion a toxina para el tratamiento de enfermedades relacionadas con infecciones por cmv.
IN2015DN02109A (pl)
BR112016029619A2 (pt) novas fluoroquinolonas e sesu usos no tratamento de infecções bacterianas
BR112019017314A2 (pt) composições farmacêuticas para terapia de combinação
ZA202202243B (en) Aqueous pharmaceutical composition of anti-pd1 antibody prolgolimab and the use thereof
CR20220620A (es) Composición farmacéutica acuosa de levilimab y su uso
ECSP21027009A (es) Derivados de 4-pirazin-2-ilmetil-morfolina y su uso como medicamento